Adverse drug reactions in Norway: A systematic review

Mojtaba Vaismoradi, Patricia Logan, Sue Jordan, H Sletvoid

Research output: Contribution to journalArticle

Abstract

Prescription medicines aim to relieve patients' suffering but they can be associated with adverse side effects or adverse drug reactions (ADRs). ADRs are an important cause of hospital admissions and a financial burden on healthcare systems across the globe. There is little integrative and collective knowledge on ADR reporting and monitoring in the Norwegian healthcare system. Accordingly, this systematic review aims to investigate the current trends in ADR reporting, monitoring, and handling in the Norwegian healthcare system and describe related interventions. Appropriate keywords, with regard to ADRs in both English and Norwegian languages, were used to retrieve articles published from 2010 to 2019. Six articles met the inclusion criteria. The findings offer a comprehensive picture of ADR reporting and monitoring in the Norwegian healthcare system. Psychotropic medicines were most commonly implicated by patients, while professionals most commonly reported ADRs associated with anticoagulants. The current ADR systems were compiled with the involvement of both patients and healthcare providers to record all types of drugs and ADRs of various severities, and aimed at improving ADR tracking. However, there is a need to improve current initiatives in terms of feedback and quality, and more studies are needed to explore how ADR profiles, and the associated vigilance, can improve the safety of medicines management in Norway.
Original languageEnglish
Article number102
Pages (from-to)1-12
Number of pages12
JournalPharmacy
Volume7
Issue number3
DOIs
Publication statusPublished - 25 Jul 2019

Fingerprint Dive into the research topics of 'Adverse drug reactions in Norway: A systematic review'. Together they form a unique fingerprint.

Cite this